Clovis Oncology Inc (NASDAQ:CLVS)

82.90
Delayed Data
As of 3:51pm ET
 -0.81 / -0.97%
Today’s Change
35.33
Today|||52-Week Range
94.88
+48.04%
Year-to-Date

Today’s Trading

Previous close83.71
Today’s open84.02
Day’s range79.29 - 86.19
Volume593,269
Average volume (3 months)574,421
Market cap$2.8B
Dividend yield--
Data as of 3:51pm ET, 04/28/2015

Growth & Valuation

Earnings growth (last year)-60.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales139.29
Price/Book8.58

Competitors

 Today’s
change
Today’s
% change
WXWuxi Pharmatech Caym...-0.76-1.88%
ANACAnacor Pharmaceutica...-3.99-6.81%
ASPXAuspex Pharmaceutica...-0.03-0.03%
TSROTESARO Inc-0.22-0.36%
Data as of 3:51pm ET, 04/28/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$1.73
Annual revenue (last year)$13.6M
Annual profit (last year)-$160.0M
Net profit margin-1,174.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
Chief Financial Officer, Secretary &
Executive VP
Erle T. Mast
Corporate headquarters
Boulder, Colorado

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers